Retrospective Study of Brachytherapy

NCT ID: NCT05242861

Last Updated: 2022-02-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-20

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Brachytherapy for gynecological cancers will be studied retrospectively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brachytherapy Uterine Cervical Neoplasms Uterine Neoplasms Vulvar Cancer Vaginal Cancer Ovarian Neoplasms Gynecologic Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cervix radical BT

Brachytherapy

Intervention Type RADIATION

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Cervix adjuvant BT

Brachytherapy

Intervention Type RADIATION

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Cervix palliative BT

Brachytherapy

Intervention Type RADIATION

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Uterus BT

Brachytherapy

Intervention Type RADIATION

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Other GO cancer BT

Brachytherapy

Intervention Type RADIATION

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brachytherapy

Applicator, dose, schedule, technology, image, 3D print, efficacy, toxicity of brachytherapy

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 - 80 female
* Underwent brachytherapy
* With gynecological cancer

Exclusion Criteria

* Refusal to enter this trial
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zhejiang Cancer Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhejiang Cancer Hospital

Hangzhou, Zhejiang, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xiang Zhang

Role: primary

0086-571-88122048

References

Explore related publications, articles, or registry entries linked to this study.

Sturdza A, Potter R, Fokdal LU, Haie-Meder C, Tan LT, Mazeron R, Petric P, Segedin B, Jurgenliemk-Schulz IM, Nomden C, Gillham C, McArdle O, Van Limbergen E, Janssen H, Hoskin P, Lowe G, Tharavichitkul E, Villafranca E, Mahantshetty U, Georg P, Kirchheiner K, Kirisits C, Tanderup K, Lindegaard JC. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol. 2016 Sep;120(3):428-433. doi: 10.1016/j.radonc.2016.03.011. Epub 2016 Apr 29.

Reference Type BACKGROUND
PMID: 27134181 (View on PubMed)

Lindegaard JC, Madsen ML, Traberg A, Meisner B, Nielsen SK, Tanderup K, Spejlborg H, Fokdal LU, Norrevang O. Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer. Radiother Oncol. 2016 Jan;118(1):173-5. doi: 10.1016/j.radonc.2015.12.012. Epub 2015 Dec 29.

Reference Type BACKGROUND
PMID: 26743833 (View on PubMed)

Sekii S, Tsujino K, Kosaka K, Yamaguchi S, Kubota H, Matsumoto Y, Ota Y, Sasaki R, Soejima T. Inversely designed, 3D-printed personalized template-guided interstitial brachytherapy for vaginal tumors. J Contemp Brachytherapy. 2018 Oct;10(5):470-477. doi: 10.5114/jcb.2018.78832. Epub 2018 Oct 9.

Reference Type BACKGROUND
PMID: 30479625 (View on PubMed)

Harris BD, Nilsson S, Poole CM. A feasibility study for using ABS plastic and a low-cost 3D printer for patient-specific brachytherapy mould design. Australas Phys Eng Sci Med. 2015 Sep;38(3):399-412. doi: 10.1007/s13246-015-0356-3. Epub 2015 Jun 25.

Reference Type BACKGROUND
PMID: 26108891 (View on PubMed)

Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):111-9. doi: 10.1016/j.ijrobp.2013.05.033. Epub 2013 Jul 9.

Reference Type RESULT
PMID: 23849695 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BTOG 2201

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.